Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 28 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05442515
- Conditions
- Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Lymphoid Leukemia, +34 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Conditions
- Acute Lymphoblastic Leukemia, B-ALL, Hematologic Diseases, +10 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
NCT07246707
- Conditions
- B-ALL
- Locations
-
- First Affiliated Hospital of Zhejiang University Hangzhou, China
NCT07328503
- Conditions
- Acute Lymphoblastic Leukemia, B-ALL, Hematologic Diseases, +10 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06579469
- Conditions
- B-ALL, Hematologic Diseases, Hematologic Malignancy, +5 more
- Locations
-
- Childrens Hospital of Colorado Aurora, Colorado, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
- Primary Children's Hospital Salt Lake City, Utah, United States
NCT04318678
- Conditions
- AML/MDS, B-ALL, BPDCN, +21 more
- Locations
-
- St Jude Children's Research Hospital Memphis, Tennessee, United States
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Recruiting
A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic Leukemia
NCT07556757
- Conditions
- B-ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Dr Jackie Thomson Inc Johannesburg, South Africa
- Alberts Cellular Therapy Pretoria, South Africa
NCT04512716
- Conditions
- B ALL, B-ALL, DLBCL, +25 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT07244406
- Conditions
- B-ALL
- Locations
-
- Peking University People's Hospital Beijing, China
Recruiting
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
NCT06689917
- Conditions
- B-ALL, B-NHL
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China Wuhan, Hubei, China
NCT06785324
- Conditions
- B Cell Acute Lymphoblastic Leukemia (B-ALL), B-ALL, Burkitt Lymphoma, +17 more
- Locations
-
- University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
Recruiting
The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
NCT06911710
- Conditions
- AML (Acute Myelogenous Leukemia), B-ALL, Blood Protein Disorders, +23 more
- Locations
-
- TianJin China. TianJin Medical University General Tianjin, Tianjin Municipality, China
Recruiting
a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B-ALL
NCT04781634
- Conditions
- B-ALL
- Locations
-
- 920th Hospital of Joint Logistics Support Force Kunming, Yunnan, China
Recruiting
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
NCT06678282
- Conditions
- B-ALL, B-NHL
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhenzhou, Henan, China
NCT07572136
- Conditions
- Acute Lymphoblastic Leukemia, B-ALL, Hematologic Diseases, +10 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Not Yet Recruiting
A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
NCT07313852
- Conditions
- B-ALL, B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Acute Lymphoblastic Leukemia, +17 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
Not Yet Recruiting
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia
NCT06902025
- Conditions
- B-ALL
- Locations
-
- The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Not Yet Recruiting
Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation
NCT06658938
- Conditions
- B-ALL
- Locations
-
Not specified
Not Yet Recruiting
The Use of Blinatumomab in Patients With NGS-MRD Relapsed B-ALL After Autologous/Allogeneic Transplantation
NCT06504186
- Conditions
- B-ALL
- Locations
-
Not specified
NCT02315612
- Conditions
- ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States